Exact Mass: 378.9782

Exact Mass Matches: 378.9782

Found 26 metabolites which its exact mass value is equals to given mass value 378.9782, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PERFLUIDONE

PERFLUIDONE

C14H12F3NO4S2 (379.016)


   

psammaplin C

psammaplin C

C11H14BrN3O5S (378.9837)


   

ZINC01032479

ZINC01032479

C17H14ClNO3S2 (379.0104)


   

ZINC1042652

ZINC1042652

C15H11BrClN3S (378.9546)


   

Maybridge3_003549

Maybridge3_003549

C14H12F3NO4S2 (379.016)


   

Convolutamine B

Convolutamine B

C13H19Br2NO2 (378.9782)


   

CHEMBL335822

CHEMBL335822

C20H11Cl2N3O (379.0279)


   

((4R,5R)-5-(4-Iodophenyl)-2-phenyl-4,5-dihydrooxazol-4-yl)methanol

((4R,5R)-5-(4-Iodophenyl)-2-phenyl-4,5-dihydrooxazol-4-yl)methanol

C16H14INO2 (379.0069)


   

2-[3-(2,6-dichlorophenyl)sulfanyl-2,5-dimethylindol-1-yl]acetic acid

2-[3-(2,6-dichlorophenyl)sulfanyl-2,5-dimethylindol-1-yl]acetic acid

C18H15Cl2NO2S (379.0201)


   

Ethyl 8-bromo-4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate

Ethyl 8-bromo-4-hydroxy-6-(trifluoromethoxy)quinoline-3-carboxylate

C13H9BrF3NO4 (378.9667)


   

3-[4-[(4-BROMOPHENYL)THIO]-3-NITROPHENYL]ACRYLIC ACID

3-[4-[(4-BROMOPHENYL)THIO]-3-NITROPHENYL]ACRYLIC ACID

C15H10BrNO4S (378.9514)


   

ETHYL 2-BROMO-4-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOLE-5-CARBOXYLATE

ETHYL 2-BROMO-4-(4-(TRIFLUOROMETHYL)PHENYL)THIAZOLE-5-CARBOXYLATE

C13H9BrF3NO2S (378.9489)


   

1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, 5-bromo-1-(phenylsulfonyl)-

1H-Pyrrolo[2,3-b]pyridine-3-carboxamide, 5-bromo-1-(phenylsulfonyl)-

C14H10BrN3O3S (378.9626)


   

2,5-dibromopyridine-3-boronic acid pinacol ester

2,5-dibromopyridine-3-boronic acid pinacol ester

C11H16BBr2NO3 (378.959)


   

N-(TRIISOPROPYLSILYL)-3,4-DIBROMOPYRROLE

N-(TRIISOPROPYLSILYL)-3,4-DIBROMOPYRROLE

C13H23Br2NSi (378.9966)


   

Deoxyribonucleic acid sodium salt

Deoxyribonucleic acid sodium salt

C17H15BrFNO3 (379.0219)


   

C13H9BrF3NO4

C13H9BrF3NO4 (378.9667)


   

4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-((5-nitrothiazol-2-yl)thio)-1H-1,2,4-triazol-5(4H)-one

4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-((5-nitrothiazol-2-yl)thio)-1H-1,2,4-triazol-5(4H)-one

C13H9N5O5S2 (379.0045)


   

Adenosine-5-(dithio)phosphate

Adenosine-5-(dithio)phosphate

C10H14N5O5PS2 (379.0174)


   

N-acetyl-D-galactosamine 4,6-disulfate

N-acetyl-D-galactosamine 4,6-disulfate

C8H13NO12S2-2 (378.9879)


   

5-[(2,4-dichlorophenoxy)methyl]-N-(2-fluorophenyl)furan-2-carboxamide

5-[(2,4-dichlorophenoxy)methyl]-N-(2-fluorophenyl)furan-2-carboxamide

C18H12Cl2FNO3 (379.0178)


   

O-304

O-304

C16H11Cl2N3O2S (378.9949)


O-304 is a first-in-class, orally available pan-AMPK activator, which increases AMPK activity by suppressing the dephosphorylation of pAMPK. O-304 exhibits a great potential as a agent to treat type 2 diabetes (T2D) and associated cardiovascular complications [1][2].

   

1-{[2-(2,6-dibromo-3-methoxyphenyl)ethyl](methyl)amino}propan-2-ol

1-{[2-(2,6-dibromo-3-methoxyphenyl)ethyl](methyl)amino}propan-2-ol

C13H19Br2NO2 (378.9782)


   

(2s)-1-{[2-(2,6-dibromo-3-methoxyphenyl)ethyl](methyl)amino}propan-2-ol

(2s)-1-{[2-(2,6-dibromo-3-methoxyphenyl)ethyl](methyl)amino}propan-2-ol

C13H19Br2NO2 (378.9782)


   

3-(3-bromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-(2-sulfamoylethyl)propanamide

3-(3-bromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-(2-sulfamoylethyl)propanamide

C11H14BrN3O5S (378.9837)


   

(2e)-3-(3-bromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-(2-sulfamoylethyl)propanimidic acid

(2e)-3-(3-bromo-4-hydroxyphenyl)-2-(n-hydroxyimino)-n-(2-sulfamoylethyl)propanimidic acid

C11H14BrN3O5S (378.9837)